Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer

15Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

β-1,3-N-acetylglucosaminyltransferase-8 (β3Gn-T8) is the most recently identifed enzyme in the β3Gn-T family, but its biological function is poorly understood. To elucidate the effects of β3Gn-T8 on gastric cancer behavior, β3Gn-T8 was down-regulated in AGS cells using small interfering RNA (siRNA). The mRNA and protein expression levels of β3Gn-T8 were detected using RT-PCR and Western blotting, respectively, and sequence-specifc inhibition using sirna was also measured using RT-PCR in human SPCA-1 and SGC-7901 cells. The cell proliferation rate was determined using MTT and the percentage of apoptotic cells was measured using fow cytometry. AGS cells transfected with β3Gn-T8 sirna were subcutaneously transplanted into nude mice and tumorigenicity was assessed. The siRNA effciently suppressed β3Gn-T8 expression in AGS cells, and the down-regulation of β3Gn-T8 caused significant inhibition of tumor cell growth in vitro. The apoptotic rate of AGS cells increased to 10.13% 48 h after siRNA transfection, which was five times that of the control cells. Furthermore, the knockdown of β3Gn-T8 expression reduced the tumorigenicity of gastric cancer cells in nude mice, suggesting that β3Gn-T8 has potential as a gastric cancer therapeutic target.

Cite

CITATION STYLE

APA

Liu, Z., Shen, L., Xu, L., Sun, X., Zhou, J., & Wu, S. (2011). Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Molecular Medicine Reports, 4(3), 497–503. https://doi.org/10.3892/mmr.2011.448

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free